Ipamorelin

Ipamorelin is a research-grade synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH₂) produced for scientific investigation of the growth hormone secretion pathway. As a selective ghrelin receptor (GHS-R1a) agonist and growth hormone secretagogue, Ipamorelin is distinguished by its high receptor specificity, reducing off-target effects associated with broader-acting compounds.

Ipamorelin stimulates pulsatile growth hormone release without elevating cortisol or prolactin levels, making it useful for studies focused on clean GH-axis activation. Ipamorelin application extends to analyzing downstream effects on body composition, bone density, metabolic regulation, and collagen synthesis within laboratory settings.

Research applications include:

• Binding kinetics and receptor specificity studies for GHS-R1a agonists
• Analysis of pulsatile growth hormone secretion patterns
• Model development for body composition and lean mass modulation
• Investigation of bone density and collagen synthesis pathways
• Neuroendocrine signalling research excluding cortisol and prolactin elevation
• Comparative studies of GH secretagogues such as Tesamorelin and other GHRPs

Product specifications:

• Form: Lyophilised powder
• Purity: ≥99%
• Storage: –20°C, protected from light and moisture
• Available strength: 10mg

⚠️ For research purposes only. This product is not intended for human or veterinary use, consumption, or self-administration. Handling must be performed by qualified professionals within a suitable laboratory environment. It has not been evaluated by regulatory authorities such as the MHRA for therapeutic applications.